Klebsiella Pneumoniae

• Uses For the temporary relief of cold and flu-like symptoms. Directions Adults and Adolescents (12 years and older): At the first sign of symptoms, take one tablet allowing it to dissolve under the tongue.

Directions Adults and Adolescents (12 years and older): At the first sign of symptoms, take one tablet allowing it to dissolve under the tongue. If symptoms persist, take one tablet two or three times during the day or as recommended by your healthcare practitioner. Children (6-11 years): Take under the direction of your healthcare practitioner.

This product is not intended to be an alternative to vaccination. Do not use if you have ever had an allergic reaction to this product or any of its ingredients. Stop use and ask a doctor if symptoms continue to persist after three days of use or are accompanied by a fever. If pregnant or breastfeeding, ask a health professional before use. Keep out of reach of children. In case of overdose, get medical help or contact a Poison Control Center right away.

In case of overdose, get medical help or contact a Poison Control Center right away.

1. 1Dementia1100%
2. 2Off Label Use1100%
3. 3Rash Pruritic1100%
4. 4Visual Impairment1100%

Recent PubMed references pinned to Klebsiella Pneumoniae as a MeSH major topic. Citations link to pubmed.ncbi.nlm.nih.gov.

• Emergence of a novel tet(X5) variant in Klebsiella spp. isolated from retail meat in Hainan, China.
  The Journal of antimicrobial chemotherapy · 2026 · Chen W, Zhai W, Wang Y, et al.
  PMID 42258602DOI 10.1093/jac/dkag192
• Epidemiological and Genomic Characteristics of bla (CTX-M) and bla (NDM)-Producing K. pneumoniae From Dairy Cows in Henan Province, China.
  Transboundary and emerging diseases · 2026 · Feng Y, Li W, Ma M, et al.
  PMID 42253327DOI 10.1155/tbed/5331014
• Ceftibuten-polymyxin B combination alters resistance and cell wall gene expression in multidrug-resistant Klebsiella pneumoniae.
  PloS one · 2026 · Sturaro MC, Silva RCCD, Simionatto S, et al.
  PMID 42247424DOI 10.1371/journal.pone.0349583
• Serum proteomic profiling of sepsis patients reveals a protein-based diagnostic model, with metabolomic insights into carbapenem-resistant Klebsiella pneumoniae infection.
  Frontiers in immunology · 2026 · He J, Luo S, Xu W, et al.
  PMID 42245654DOI 10.3389/fimmu.2026.1818068
• TadA-mediated A-to-I mRNA editing rewires redox metabolism to promote dominance of epidemic Klebsiella pneumoniae clones.
  Proceedings of the National Academy of Sciences of the United States of America · 2026 · Wu X, Jin L, Wang Q, et al.
  PMID 42228542DOI 10.1073/pnas.2536397123
• Genomic analysis reveals multi-level resistance network linking oxidative stress pathway mutations to cefiderocol resistance and clonal evolution in Klebsiella pneumoniae from the United Arab Emirates.
  Frontiers in cellular and infection microbiology · 2026 · Daoud L, Collyns T, Ghazawi A, et al.
  PMID 42221590DOI 10.3389/fcimb.2026.1820198
• Genomic and functional characterization of a novel halophilic bacteriophage targeting carbapenem-resistant Klebsiella pneumoniae.
  PloS one · 2026 · Abed S, Beig M, Soltani S, et al.
  PMID 42207801DOI 10.1371/journal.pone.0348054
• Cyclomodulins and supplementary virulence genes as determinants of clinical severity and antimicrobial resistance in uropathogenic Escherichia coli and Klebsiella pneumoniae.
  World journal of microbiology & biotechnology · 2026 · Monroy-Higuera J, Angulo-Zamudio UA, Leon-Sicairos N, et al.
  PMID 42207375DOI 10.1007/s11274-026-05045-2

The 10 most recently updated of 74 ClinicalTrials.gov registrations naming Klebsiella Pneumoniae as an intervention. Registration is not evidence of efficacy or safety — reference crosswalk only.

• Epidemiology of Carbapenemase-producing Bacteria in a Swiss Tertiary Care Hospital
  Recruiting · Observational · 100 enrolled · University Hospital, Basel, Switzerland
  NCT04098133updated 2026-06-08
• Oral Bacterial Extract for the Prevention of Wheezing Lower Respiratory Tract Illness
  Completed · Phase 2 · Interventional · 822 enrolled · University of Arizona
  NCT02148796updated 2026-06-02
• Hypervirulent Amoxicillin-Susceptible Klebsiella Pneumoniae CC66, France, 2016-2023
  Completed · Observational · 56 enrolled · Centre Hospitalier Universitaire de Nice
  NCT07598006updated 2026-05-20
• Pyogenic Liver Abcess in Guadeloupe
  Completed · Observational · 58 enrolled · Centre Hospitalier Universitaire de la Guadeloupe
  NCT07579104updated 2026-05-11
• Phenotypic and Genotypic Detection of Biofilm Formation and Efflux Pump Activity in Multi-drug Resistant Klebsiella Pneumoniae
  Not yet recruiting · Observational · 100 enrolled · Sohag University
  NCT07541690updated 2026-04-21
• Impact of Siderophore Genes on Cefiderocol Susceptibility in Carbapenem Resistant Hypervirulent Klebsiella Pneumoniae
  Not yet recruiting · Observational · 100 enrolled · Sohag University
  NCT07475429updated 2026-03-24
• Bacteriophages in Addition to Antibiotics for the Treatment of Patients With Infective Endocarditis
  Recruiting · Phase 3 · Interventional · 30 enrolled · University Clinical Hospital na V.V.Vinogradov (branch of RUDN university na Patrice Lumumba)
  NCT06870409updated 2026-03-19
• Gram-Negative Bloodstream Infection Oral Antibiotic Therapy Trial
  Recruiting · Interventional · 1,030 enrolled · Johns Hopkins University
  NCT06080698updated 2026-03-11
• Evaluation of Safety and Efficacy of Phage Therapy for Drug-resistant Bacterial Infections: An Exploratory, Prospective Single-arm Study
  Not yet recruiting · Interventional · 6 enrolled · The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
  NCT07382271updated 2026-02-02
• Effect of Ceftazidime-Avibactam on Carbapenemase-Producing Klebsiella Pneumoniae
  Not yet recruiting · Observational · 100 enrolled · Sohag University
  NCT07369518updated 2026-01-27

Frequently asked questions

What is Klebsiella Pneumoniae used for?

According to FDA labeling, Klebsiella Pneumoniae carries indications including: Uses For the temporary relief of cold and flu-like symptoms. Directions Adults and Adolescents (12 years and older): At the first sign of symptoms, take one tablet allowing it to dissolve under the tongue.. This is a reference summary of labeled uses, not medical advice or a treatment recommendation.